Bambermycin structure
|
Common Name | Bambermycin | ||
|---|---|---|---|---|
| CAS Number | 11015-37-5 | Molecular Weight | 1582.583 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C69H107N4O35P | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of BambermycinMoenomycin complex is a potent transglycosylase inhibitor. Moenomycin complex inhibits bacterial growth by blocking the transglycosylase activity of class A penicillin-binding proteins (PBPs)[1]. |
| Name | bambermycin |
|---|---|
| Synonym | More Synonyms |
| Description | Moenomycin complex is a potent transglycosylase inhibitor. Moenomycin complex inhibits bacterial growth by blocking the transglycosylase activity of class A penicillin-binding proteins (PBPs)[1]. |
|---|---|
| Related Catalog | |
| Target |
Transglycosylase[1] |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C69H107N4O35P |
| Molecular Weight | 1582.583 |
| Exact Mass | 1581.661377 |
| PSA | 611.69000 |
| LogP | 4.81 |
| Index of Refraction | 1.615 |
| InChIKey | PERZMHJGZKHNGU-UHFFFAOYSA-N |
| SMILES | C=C(CC=C(C)CCC=C(C)C)CCC(C)(C)C=CCCC(C)=CCOC(COP(=O)(O)OC1OC(C(=O)O)C(C)(O)C(OC(N)=O)C1OC1OC(COC2OC(CO)C(O)C(O)C2O)C(OC2OC(C)C(OC3OC(C(=O)NC4=C(O)CCC4=O)C(O)C(O)C3O)C(O)C2NC(C)=O)C(O)C1NC(C)=O)C(=O)O |
| Storage condition | 0-6°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
Positive cooperativity between acceptor and donor sites of the peptidoglycan glycosyltransferase.
Biochem. Pharmacol. 93(2) , 141-50, (2015) The glycosyltransferases of family 51 (GT51) catalyze the polymerization of lipid II to form linear glycan chains, which, after cross linking by the transpeptidases, form the net-like peptidoglycan ma... |
|
|
Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota.
Regul Toxicol Pharmacol 53(3) , 209-16, (2009) Trace levels of veterinary antibiotics that reside in livestock products may disturb the balance of human intestinal microbiota and impair the colonized barrier function, which is critical to protect ... |
|
|
Effect of flavophospholipol on conjugation frequency between Escherichia coli donor and recipient pairs in vitro and in the chicken gastrointestinal tract.
J. Antimicrob. Chemother. 58(2) , 359-66, (2006) To examine the ability of flavophospholipol to inhibit bacterial conjugation between Escherichia coli donor and recipient pairs in vitro and in day-of-hatch chickens.In vitro donor cultures were incub... |
| (2R)-3-{[{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-Acetamido-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrah |
| Moenomycine |
| MOENOMYCIN |
| menomycin |
| Bambermycine |
| BAMBERMYCIN |
| BAMBERMYCINS |
| flavophospholipol |
| Flavomycin |
| moenomycin a |